72 related articles for article (PubMed ID: 21236712)
1. A WNK4 gene variant relates to osteoporosis and not to hypertension in the Portuguese population.
Mendes AI; Mascarenhas MR; Matos S; Sousa I; Ferreira J; Barbosa AP; Bicho M; Jordan P
Mol Genet Metab; 2011 Apr; 102(4):465-9. PubMed ID: 21236712
[TBL] [Abstract][Full Text] [Related]
2. Three novel missense mutations of WNK4, a kinase mutated in inherited hypertension, in Japanese hypertensives: implication of clinical phenotypes.
Kamide K; Takiuchi S; Tanaka C; Miwa Y; Yoshii M; Horio T; Mannami T; Kokubo Y; Tomoike H; Kawano Y; Miyata T
Am J Hypertens; 2004 May; 17(5 Pt 1):446-9. PubMed ID: 15110905
[TBL] [Abstract][Full Text] [Related]
3. Hypercalciuria in familial hyperkalemia and hypertension accompanies hyperkalemia and precedes hypertension: description of a large family with the Q565E WNK4 mutation.
Mayan H; Munter G; Shaharabany M; Mouallem M; Pauzner R; Holtzman EJ; Farfel Z
J Clin Endocrinol Metab; 2004 Aug; 89(8):4025-30. PubMed ID: 15292344
[TBL] [Abstract][Full Text] [Related]
4. Resolution of hypertension during pregnancy in familial hyperkalemia and hypertension with the WNK4 Q565E mutation.
Mayan H; Mouallem M; Shaharabany M; Pauzner R; Farfel Z
Am J Obstet Gynecol; 2005 Feb; 192(2):598-603. PubMed ID: 15696009
[TBL] [Abstract][Full Text] [Related]
5. WNK4 polymorphisms and essential hypertension in the Uyghur population.
Lu M; Wang X; Wang F; Wang S; Lin R; Wang S; Wen H; Jin L
Clin Exp Hypertens; 2009 Apr; 31(2):179-85. PubMed ID: 19330605
[TBL] [Abstract][Full Text] [Related]
6. [Correlation analysis between WNK4 gene and essential hypertension].
Sun ZJ; Wang XN; Lu JY; Ding Q; Dong LY; Zhao YY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):145-8. PubMed ID: 12905707
[TBL] [Abstract][Full Text] [Related]
7. Association of Ala589Ser polymorphism of WNK4 gene with essential hypertension in a high-risk Chinese population.
Sun ZJ; Li Y; Lu JY; Ding Q; Liang Y; Shi JP; Li-Ling J; Zhao YY
J Physiol Sci; 2009 Mar; 59(2):81-6. PubMed ID: 19340547
[TBL] [Abstract][Full Text] [Related]
8. Increased urinary Na-Cl cotransporter protein in familial hyperkalaemia and hypertension.
Mayan H; Attar-Herzberg D; Shaharabany M; Holtzman EJ; Farfel Z
Nephrol Dial Transplant; 2008 Feb; 23(2):492-6. PubMed ID: 17951312
[TBL] [Abstract][Full Text] [Related]
9. Pseudohypoaldosteronism type 2 presenting with hypertension and hyperkalaemia due to a novel mutation in the WNK4 gene.
Brooks AM; Owens M; Sayer JA; Salzmann M; Ellard S; Vaidya B
QJM; 2012 Aug; 105(8):791-4. PubMed ID: 21764813
[No Abstract] [Full Text] [Related]
10. WNK4 intron 10 polymorphism is not associated with hypertension.
Speirs HJ; Morris BJ
Hypertension; 2004 Apr; 43(4):766-8. PubMed ID: 14967840
[TBL] [Abstract][Full Text] [Related]
11. Low prevalence of nonconservative mutations of serum and glucocorticoid-regulated kinase (SGK1) gene in hypertensive and renal patients.
Trochen N; Ganapathipillai S; Ferrari P; Frey BM; Frey FJ
Nephrol Dial Transplant; 2004 Oct; 19(10):2499-504. PubMed ID: 15304560
[TBL] [Abstract][Full Text] [Related]
12. Genetic variants of WNK4 in whites and African Americans with hypertension.
Erlich PM; Cui J; Chazaro I; Farrer LA; Baldwin CT; Gavras H; DeStefano AL
Hypertension; 2003 Jun; 41(6):1191-5. PubMed ID: 12719438
[TBL] [Abstract][Full Text] [Related]
13. WNK4 enhances TRPV5-mediated calcium transport: potential role in hypercalciuria of familial hyperkalemic hypertension caused by gene mutation of WNK4.
Jiang Y; Ferguson WB; Peng JB
Am J Physiol Renal Physiol; 2007 Feb; 292(2):F545-54. PubMed ID: 17018846
[TBL] [Abstract][Full Text] [Related]
14. A patient with pseudohypoaldosteronism type II caused by a novel mutation in WNK4 gene.
Gong H; Tang Z; Yang Y; Sun L; Zhang W; Wang W; Cui B; Ning G
Endocrine; 2008 Jun; 33(3):230-4. PubMed ID: 19016006
[TBL] [Abstract][Full Text] [Related]
15. Association of EDNRA, but not WNK4 or FKBP1B, polymorphisms with essential hypertension.
Benjafield AV; Katyk K; Morris BJ
Clin Genet; 2003 Nov; 64(5):433-8. PubMed ID: 14616768
[TBL] [Abstract][Full Text] [Related]
16. A familial case of pseudohypoaldosteronism type II (PHA2) with a novel mutation (D564N) in the acidic motif in WNK4.
Sakoh T; Sekine A; Mori T; Mizuno H; Kawada M; Hiramatsu R; Hasegawa E; Hayami N; Yamanouchi M; Suwabe T; Sawa N; Ubara Y; Fujimaru T; Sohara E; Shinichi U; Hoshino J; Takaichi K
Mol Genet Genomic Med; 2019 Jun; 7(6):e705. PubMed ID: 31044551
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive assessment of the association of WNK4 polymorphisms with hypertension: evidence from a meta-analysis.
Guo XG; Ding J; Xu H; Xuan TM; Jin WQ; Yin X; Shang YP; Zhang FR; Zhu JH; Zheng LR
Sci Rep; 2014 Sep; 4():6507. PubMed ID: 25266424
[TBL] [Abstract][Full Text] [Related]
18. Familial hyperkalemia and hypertension: pathogenetic insights based on lithium clearance.
Mayan H; Melnikov S; Novikov I; Holtzman EJ; Farfel Z
J Clin Endocrinol Metab; 2009 Aug; 94(8):3010-6. PubMed ID: 19491230
[TBL] [Abstract][Full Text] [Related]
19. Missense mutations in LRP5 are not a common cause of idiopathic osteoporosis in adult men.
Crabbe P; Balemans W; Willaert A; van Pottelbergh I; Cleiren E; Coucke PJ; Ai M; Goemaere S; van Hul W; de Paepe A; Kaufman JM
J Bone Miner Res; 2005 Nov; 20(11):1951-9. PubMed ID: 16234968
[TBL] [Abstract][Full Text] [Related]
20. Impaired KLHL3-mediated ubiquitination of WNK4 causes human hypertension.
Wakabayashi M; Mori T; Isobe K; Sohara E; Susa K; Araki Y; Chiga M; Kikuchi E; Nomura N; Mori Y; Matsuo H; Murata T; Nomura S; Asano T; Kawaguchi H; Nonoyama S; Rai T; Sasaki S; Uchida S
Cell Rep; 2013 Mar; 3(3):858-68. PubMed ID: 23453970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
